Clinical Trials Browser

OTHER × varlilumab × CNS × Clear all

NCT03688178 2026-05-22

DERIVe

Phase 2 Active not recruiting

Glioblastoma

NCT02924038 2024-06-14

A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)

Phase 1 Terminated

14 enrolled 10 charts

Astrocytoma, Glioma, Lymphoma, Follicular, Oligodendroglioma